Autoimmune disease therapy spinout Cabaletta Bio's series B round brought its total to at least $88m allowed the university to pare back its shareholding.
Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.
UAVC has returned to back UA-founded hospitality staffing platform Qwick after investing an undisclosed sum in November 2018.
Boston Scientific has exercised its option to wholly acquire Millipede, based on research at Michigan, having purchased a $90m stake in the mitral regurgitation treatment device maker last year.
UC Berkeley spinout Iota Biosciences has obtained $15m in series A capital from investors including Astellas.
Stanford-StartX Fund has returned to pump funding into electric skateboard manufacturer Boosted, helping to take the company’s total funding to $70m.
MIT retail analytics spinout Celect has now raised a total of $25m, having received $15m in an NGP Partners-led round.
Co-founded by an Indiana University graduate, customer behaviour analytics software developer Zio has secured funding from two of the university’s venture funds.
Osage University Partners was among the investors to supply seed funding for robotic technology developer Elementary Robotics.
Immunotherapy spinout Annexon Biosciences collected funding from Novartis Venture Fund in a series C round that brought its total funding to $154m.